(Updated - November 22, 2024 6:19 AM EST)

Leerink Partners analyst Jeffrey La Rosa upgraded Abbvie (NYSE: ABBV) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE